Literature DB >> 26759393

Kaposi's sarcoma presenting as violaceous macules on the chest of a kidney transplanted patient.

João Borges-Costa1, Leonor Lopes2, Luís Soares-Almeida3, José Guerra4.   

Abstract

Organ transplant recipients have a high incidence of cancer associated with persistent viral infections, such as human herpes virus 8. This virus is associated with Kaposi's sarcoma, and a change in the dose or type of immunosuppression regimen should be the first step in its treatment. A multidisciplinary approach with nephrologists, dermatologists and oncologists is necessary for the management of this disease. We report a clinical case with atypical presentation and discuss the treatment options. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26759393      PMCID： PMC4716442          DOI： 10.1136/bcr-2015-210999

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  12 in total

1.  Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry.

Authors:  E S Woodle; M Hanaway; J Buell; T Gross; M R First; J Trofe; T Beebe
Journal:  Transplant Proc       Date:  2001 Nov-Dec       Impact factor: 1.066

Review 2.  Skin cancers after organ transplantation.

Authors:  Sylvie Euvrard; Jean Kanitakis; Alain Claudy
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

3.  Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

Authors:  Giovanni Stallone; Antonio Schena; Barbara Infante; Salvatore Di Paolo; Antonella Loverre; Giulio Maggio; Elena Ranieri; Loreto Gesualdo; Francesco Paolo Schena; Giuseppe Grandaliano
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

Review 4.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

5.  Sirolimus conversion for patients with posttransplant Kaposi's sarcoma.

Authors:  C Lebbé; S Euvrard; B Barrou; C Pouteil-Noble; J L Garnier; D Glotz; C Legendre; C Francès
Journal:  Am J Transplant       Date:  2006-06-19       Impact factor: 8.086

Review 6.  De novo malignancies after organ transplantation: focus on viral infections.

Authors:  P Piselli; G Busnach; L Fratino; F Citterio; G M Ettorre; P De Paoli; D Serraino
Journal:  Curr Mol Med       Date:  2013-08       Impact factor: 2.222

7.  Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience.

Authors:  G Zavos; D Moris; S Vernadakis; J Bokos; S Lionaki; G Mamarelis; K Panagiotellis; V Zavvos; I Boletis
Journal:  Transplant Proc       Date:  2014-11       Impact factor: 1.066

Review 8.  Dermatopathology of skin cancer in solid organ transplant recipients.

Authors:  Benjamin Stoff; Catherine Salisbury; Douglas Parker; Fiona O'Reilly Zwald
Journal:  Transplant Rev (Orlando)       Date:  2010-08-14       Impact factor: 3.943

9.  Kaposi sarcoma in kidney transplanted patients.

Authors:  H Shahbazian
Journal:  Urol J       Date:  2004       Impact factor: 1.510

10.  The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival.

Authors:  C Francès; A G Marcelin; Ch Legendre; S Chevret; E Dussaix; J Lejeune; S Euvrard; A Bigorie; T F Schulz; F Agbalika; C Lebbé
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.